MedTrace Logo

Study on Water Vapor Thermal Therapy

NCT06656689 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-11-06

No results posted yet for this study

Summary

The goal of this observational study is to learn about the efficacy of Rezum water vapor thermal therapy in benign prostatic hyperplasia patients. The main question it aims to answer is:

* Is Rezum an effective treatment?
* Is Rezum safe?

Participants will be followed up for at least three months after the treatment to evaluate efficacy and safety.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

PROCEDURE

Rezum (water vapor thermal therapy)

Rezum or water vapor thermal therapy is a procedure that involves injecting steam at 103°C into the prostate tissue to induce necrosis and reduce the size of the enlarged prostate.

Sponsors & Collaborators

  • Saint Vincent's Hospital, Korea

    lead OTHER

Principal Investigators

  • Hee Youn Kim, M.D., Ph.D. · St Vincent's Hospital

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-31
Primary Completion
2028-07-31
Completion
2028-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06656689 on ClinicalTrials.gov